Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05864326
Other study ID # 2022-02120
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 16, 2023
Est. completion date December 31, 2024

Study information

Verified date November 2023
Source University Hospital, Geneva
Contact Valeria Lombardi Fäh, Dr
Phone +41796138239
Email valeria.lombardifah@hcuge.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process Induction of Labor using Balloon catheter (BC). The primary objective of the study is to determine if the use of heated saline in the BC used for cervical ripening reduces the length of BC duration. Participants will be allocated to : - Intervention or warm group: the BC will be filled with heated saline water up to 40° C - Standard or room temperature group: the BC will be filled with saline water at room temperature.


Description:

Background and Rationale: Induction of Labor (IOL) is one of the most common interventions in obstetrics. IOL is performed due to fetal, maternal or pregnancy complications to reduce the risk of complication. IOL methods will depend of the state of the cervix at the beginning of the procedure. If cervix is considered unfavorable (Bishop score ≤ 5) an initial phase of ripening is usually proposed. There are various methods of cervical ripening, which can be divided into non-pharmacological (e.g., mechanical methods with transcervical Foley catheter or Cook balloon) and pharmacological (e.g., prostaglandins). IOL can be a long-lasting procedure, especially when cervical ripening is necessary. Two recent, small studies have shown that the use of warm fluid to inflate the balloon catheter (BC) inserted through the cervix reduces the time of cervical ripening, hence potentially reducing the time of IOL. These results are the only data available regarding the use of saline at different temperatures for inflating the balloon in mechanical methods and show promising effects in terms of reduction in the length of the cervical ripening and labor. The cervix is mainly composed of collagen. Studies show that the use of heat on connective tissue increase the potential elongation of collagen tissue and the denaturation of this protein. We hypothesize that the use of heat in the cervical ripening can accelerate the denaturation of the collagen and accelerate the softening of the cervix and therefore reduce the duration of cervical ripening and labor. Objective(s): The primary objective of the study is to determine if the use of heated saline in the BC used for cervical ripening reduces the length of BC duration, defined as the time from the insertion to the expulsion or artificial removal of the BC. The secondary objectives are to evaluate if the use of heated saline compared with room temperature: 1. Decreases the length from the start of the induction until the achievement of a favorable cervix (Bishop score >5). 2. Decreases the length from the start of the induction until full dilation 3. Decreases the length from the start of the induction until delivery 4. Increases the rate and the speed of spontaneous rupture of membranes (ROM) during cervical ripening 5. Impacts on the rate of cesarean delivery. 6. Impacts on the pain and the satisfaction in women undergoing cervical ripening 7. Impacts on obstetrical and neonatal complications Study Design: Prospective, single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process IOL using Balloon catheter Number of Participants with Rationale: A total of 290 women will be recruited (145 women in each group) in order to show a reduction in the duration of BC placement, considering a significance criterion set to 0.05 (alpha, two- tailed), and an expected power of at least 90%. Study procedures: Patients will be allocated in one of this two groups: - Intervention or warm group: the BC will be filled with heated saline water up to 40° C - Standard or room temperature group: the BC will be filled with saline water at room temperature. In both groups, the insertion of the BC will be done following the same procedure: The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of saline water (NaCl 0.9%) -either heated or unheated, depending on the allocation group- according to the mechanic resistance with a graduated syringe. Statistical Considerations Main analysis will be performed on an intention-to-treat basis. The main outcome will be evaluated by plotting survival functions according to the allocation group, using the Kaplan-Meier estimator. The associations will be considered as statistically significant when the p-value is below 0.05 (probability of type I error = 0.05). This analysis is also planned for objectives 2 (interval from beginning of IOL and achievement of a favorable cervix) and 3 (interval from beginning of IOL and delivery). For the other outcomes, comparison will be performed using Fisher's exact test, Student's t-test or the Mann-Whitney U test, according to the type of variable.


Recruitment information / eligibility

Status Recruiting
Enrollment 290
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 16 Years and older
Eligibility Inclusion Criteria: - Gestational age at or over 35 weeks - Singleton pregnancy - Alive fetus - Cephalic presentation - Maternal age = 16 years Exclusion Criteria: - Active labor (dilated cervix with spontaneous uterine contractions) - Prelabor rupture of membranes - >1 Previous cesarean delivery - Fetal malformation leading to a possible obstruction of labor (e.g., hydrocephaly, exteriorized fetal tumors, etc.) - Maternal or fetal disease with indication to accelerate labor (start oxytocin stimulation within 6 hours after insertion of the BC (e.g., pre-eclampsia, chorioamnionitis, etc.)] - Counterindication to vaginal delivery - Impossibility to give consent to participation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Warm group
The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of Heated saline water (NaCl 0.9%) at 40°C - according to the mechanic resistance with a graduated syringe.
Room temperature group
The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of unheated saline water (NaCl 0.9%) - according to the mechanic resistance with a graduated syringe.

Locations

Country Name City State
Switzerland Hôpitaux Universitaires de Genève Geneva Genève

Sponsors (1)

Lead Sponsor Collaborator
Begona Martinez de Tejada

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine if the use of heated saline in the Balloon Catheter (BC), used for cervical ripening, reduces the length of BC duration, defined as the time from the insertion to spontaneous expulsion or artificial removal of the BC. Duration of BC (i.e., positioning of the transcervical catheter): interval between insertion and retrieval, either after spontaneous expulsion or artificial retrieval. Through study completion, an average of 1.5 years
Secondary To evaluate if the use of heated saline compared with room temperature Decreases the length from the start of the induction until the achievement of a favorable cervix (Bishop score >5) Length of cervical ripening phase, defined as the interval between catheter insertion and the achievement of a favorable cervix, defined as Bishop score >5. Through study completion, an average of 1.5 years
Secondary Decreases the length from the start of the induction until full dilation Length from the start of the BC insertion until fully dilation Through study completion, an average of 1.5 years
Secondary Decreases the length from the start of the induction until the delivery Length from the start of the BC insertion until the delivery Through study completion, an average of 1.5 years
Secondary Increases the rate and the speed of spontaneous rupture of membranes (ROM) during cervical ripening Spontaneous rupture of membranes (ROM) during cervical ripening or labor (Yes/No)
- If Yes, length from the insertion of the BC until spontaneous ROM.
Through study completion, an average of 1.5 years
Secondary Impacts on the rate of cesarean delivery Mode of delivery (vaginal delivery vs. cesarean delivery) Through study completion, an average of 1.5 years
Secondary Impacts on the pain and the satisfaction in women undergoing cervical ripening Pain after catheter insertion assessed using a numeric rating scale (NRS, where NRS = 0 equals no pain and NRS = 10 represents the worst possible pain suffered by the participant). Participants satisfaction of the whole using a five-point Likert scale (1, very dissatisfied; 2, dissatisfied; 3, Enough Satisfied; 4, Satisfied; and 5, very satisfied) Through study completion, an average of 1.5 years
Secondary Impacts on obstetrical and neonatal complications Presence of obstetrical complications or neonatal complications Through study completion, an average of 1.5 years
See also
  Status Clinical Trial Phase
Completed NCT01127581 - Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery Phase 3
Completed NCT01139801 - Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon N/A
Active, not recruiting NCT06324279 - Cervical Sliding Sign to Predict Outcome of Induction of Labor
Active, not recruiting NCT06056141 - Induction of Labour at Term With Low Dose Oral Misoprostol Versus a Foley Catheter Phase 4
Completed NCT04529837 - Ultrasound Assessment of DILAPAN-S
Completed NCT02477085 - Methods of Labor Induction and Perinatal Outcomes
Completed NCT03138252 - Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin Phase 3
Completed NCT02098421 - Foley Labor Induction Trial at Term and in PROM Phase 1
Recruiting NCT01720394 - Efficacy of Induction of Labor on Term Using a Double Balloon Catheter Compared to Dinoprostone Vaginal-insert Phase 4
Completed NCT00451308 - Induction of Labor With a Foley Balloon Catheter: Inflation With 30ml Compared to 60ml Phase 4
Not yet recruiting NCT05511727 - Use of Single Versus Double Foley's Catheter in Pre-induction Cervical Ripening N/A
Recruiting NCT02762942 - Comparison of Vaginal Misoprostol Plus Supracervical Balloon Versus Vaginal Misoprostol Alone for Induction of Labor Phase 4
Completed NCT01283022 - Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study) Phase 2
Recruiting NCT00684606 - Transcervical Foley Catheter With or Without Oxytocin for Induction of Labor N/A
Recruiting NCT05759364 - The Effect of IV PAPAVERINE 80 mg Prior to Catheter Balloon Insertion on Bishop Score and Pain N/A
Recruiting NCT03854383 - Using Isosorbide Mononitrate in Reducing Time in Induction of Labor in Post Date Women Phase 2
Completed NCT01428037 - Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of Labor Phase 3
Terminated NCT03752073 - Comparison of Two Mechanical Methods of Outpatient Ripening of the Cervix N/A
Recruiting NCT03045939 - Cervical Ripening With the Double Balloon Device for 6 Hours Compared With 12 Hours N/A
Completed NCT03976037 - Buccal Versus Vaginal Misoprostol In Combination With Foley Bulb Early Phase 1